News Behind 4 Uncommon Stories (RNN, NXPI, GNBT, YGE)

Los Angelas, CA -- (SBWIRE) -- 02/04/2013 -- Rexahn Pharmaceuticals, Inc. (NYSE:RNN) stock gained 3.13% to $0.330 after Maxim Group initiated coverage on shares of Rexahn in a research report released on Jan. 30. The firm issued a buy rating and a $1.50 price target on the stock.

Where Is Rexahn Pharma Headed Exactly After Achieving This Milestone? Find Out Here

NXP Semiconductors NV (NASDAQ:NXPI) is currently trading at down 1.9% to $30.18 in early trading, below the offer price of $30.35 a share. NXP Semiconductors NV is a semiconductor company providing high performance mixed signal and standard product solutions. Its solutions are used for automotive, identification, wireless infrastructure, lighting, consumer and computing applications.

Should NXPI a Buy or Sell Now? Find Out Here

Generex Biotechnology Corporation (OTC:GNBT) plunged 11.11% and closed at $0.04 on a traded volume of 18.82 million shares. The Company explained the potential of the technology platform used as the basis for its novel breast cancer immunotherapy product AE37. AE37 is currently in late Phase IIb clinical development and has garnered considerable attention based upon favourable results from interim analysis of its controlled, randomized, and blinded trial in women with early stage breast cancer.

Is GNBT a Solid Investment at These Levels? Find Out Here

Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) shares increased 5.54% and closed at $3.05 in yesterday’s session. YGE’s stock was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued to investors on Jan. 30. The firm currently has a $3.10 price target on the stock.

Will The YGE Split Boost Share Price Among Huge Volatility? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com